EUVIMEDEUVIMED entdecken
Crossref

Peptide Substitutes of PEG: Biological Outcomes on Prospective Lipid Nanoparticle Shielding Materials

Rajesh Mukthavaram, Steven P Tanis, Amit Sagi, Parsa Parirokh, Michael Davis, Hyojung Hong, Hannah Pham Huynh, Michelle Nguyen, Robin Lee, Yurong Guo, Ramon Diaz Trelles, Kiyoshi Tachikawa und 11 weitere

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202505392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Rajesh Mukthavaram und 22 weiteren Autor:innen. Beteiligte Einrichtung: Arcturus Therapeutics Inc., San Diego, California, USA. Hauptthemen laut MEDLINE: Polyethylene Glycols, Nanoparticles, Lipids, Peptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polyethylene glycol (PEG) is a proven component in lipid nanoparticles (LNPs). PEGylated nanoparticles are known to improve LNP circulation half‐life and opsonization profiles. However, the drawbacks of PEG are hypersensitivity reactions due to pre‐existing PEG antibodies and poor biodegradability. These factors warrant a search for alternatives. Some large peptides have shown potent stealth properties in protein delivery. Here, we demonstrate that repeating units of serine‐threonine‐glutamic acid‐proline (STEP) peptide conjugated to dimyristoylglycerol (DMG‐STEP) and incorporated into lipid nanoparticles can perform as functional equivalents of DMG‐PEG. LNPs with DMG‐STEPs displayed similar physicochemical attributes and comparable Factor VII (FVII) silencing and human erythropoietin (hEPO) expression in both mouse and nonhuman primate animal models, with comparable biodistribution profile in mice. Additionally, DMG‐STEP LNPs encapsulating mRNA encoding for SARS‐CoV‐2 Spike protein (Wuhan variant) demonstrated superior humoral immune response in a mouse study. In addition, the preliminary safety of STEP LNPs was demonstrated by quantifying liver enzymes, cytokine induction, complement activation, and anti‐STEP antibody production. Results demonstrated comparable or even reduced cytokine induction responses with STEP LNPs compared to control PEG LNPs. The data presented supports translational potential of STEP LNPs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polyethylene GlycolsNanoparticlesLipidsPeptidesAnimalsMiceHumansFactor VIIFemaleTissue DistributionErythropoietinSARS-CoV-2Liposomes

Stichwörter der Autor:innen

lipidslipopeptidesmRNAnanoparticlesshielding materials

Substanzen

Polyethylene GlycolsLipidsFactor VIILipid NanoparticlesPeptidesErythropoietinLiposomes

Autor:innen und Institutionen

  • Arcturus Therapeutics Inc., San Diego, California, USA.

ORCID-Profile: Kumar Rajappan, Padmanabh Chivukula

Zitieren

APA

Mukthavaram, R., Tanis, S. P., Sagi, A., Parirokh, P., Davis, M., Hong, H., Huynh, H. P., Nguyen, M., Lee, R., Guo, Y., Trelles, R. D., Tachikawa, K., Dam, T., Sablad, M., Acharya, G., Dukanovic, A., Soontornniyomkij, B., Sacchetti, C., Martinez-Redondo, P., …, & Chivukula, P. (2026). Peptide Substitutes of PEG: Biological Outcomes on Prospective Lipid Nanoparticle Shielding Materials. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202505392

Vancouver

Mukthavaram R, Tanis SP, Sagi A, Parirokh P, Davis M, Hong H, et al. Peptide Substitutes of PEG: Biological Outcomes on Prospective Lipid Nanoparticle Shielding Materials. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202505392

BibTeX
@article{Mukthavaram2026,
  author = {Mukthavaram, Rajesh and Tanis, Steven P and Sagi, Amit and Parirokh, Parsa and Davis, Michael and Hong, Hyojung and Huynh, Hannah Pham and Nguyen, Michelle and Lee, Robin and Guo, Yurong and Trelles, Ramon Diaz and Tachikawa, Kiyoshi and Dam, Thanhchau and Sablad, Marciano and Acharya, Grishma and Dukanovic, Adrian and Soontornniyomkij, Benchawanna and Sacchetti, Cristiano and Martinez-Redondo, Paloma and Sullivan, Brian M and Karmali, Priya P and Rajappan, Kumar and Chivukula, Padmanabh},
  title = {Peptide Substitutes of PEG: Biological Outcomes on Prospective Lipid Nanoparticle Shielding Materials},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202505392}
}
Kostenlos starten →